title: Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings: no.
authors: Clinical Cardiology, C-NET Research Group, LIGHT, Faculty of Medicine, University of Leeds, UK. Dr.Marty@bellnet.ca
authors: Martin H
authors: MH
authors: Strauss
authors: Alistair
authors: A
authors: Hall
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects* / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists; D002986:Clinical Trials as Topic; D006801:Humans; D020521:Stroke / Q000517:prevention & control*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D057911:Angiotensin Receptor Antagonists